Analyzing the Price-to-Earnings Ratio of Rapid Micro Biosystems Inc (RPID)

The 36-month beta value for RPID is also noteworthy at 1.15. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for RPID is 20.73M, and at present, short sellers hold a 6.78% of that float. The average trading volume of RPID on May 12, 2025 was 433.51K shares.

RPID) stock’s latest price update

The stock of Rapid Micro Biosystems Inc (NASDAQ: RPID) has increased by 25.71 when compared to last closing price of 2.45.Despite this, the company has seen a gain of 30.51% in its stock price over the last five trading days. seekingalpha.com reported 2025-05-09 that Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Mike Beaulieu – VP, IR and Corporate Communications Rob Spignesi – President and CEO Sean Wirtjes – CFO Conference Call Participants Dan Arias – Stifel Paul Knight – KeyBanc Capital Markets Chad Wiatrowski – TD Cowen Operator Thank you for standing by. My name is RG, and I will be your conference operator today.

RPID’s Market Performance

Rapid Micro Biosystems Inc (RPID) has experienced a 30.51% rise in stock performance for the past week, with a 41.94% rise in the past month, and a 4.05% rise in the past quarter. The volatility ratio for the week is 10.90%, and the volatility levels for the past 30 days are at 8.70% for RPID. The simple moving average for the past 20 days is 31.88% for RPID’s stock, with a 101.59% simple moving average for the past 200 days.

Analysts’ Opinion of RPID

Many brokerage firms have already submitted their reports for RPID stocks, with KeyBanc Capital Markets repeating the rating for RPID by listing it as a “Overweight.” The predicted price for RPID in the upcoming period, according to KeyBanc Capital Markets is $8 based on the research report published on February 12, 2025 of the current year 2025.

RPID Trading at 27.92% from the 50-Day Moving Average

After a stumble in the market that brought RPID to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.84% of loss for the given period.

Volatility was left at 8.70%, however, over the last 30 days, the volatility rate increased by 10.90%, as shares surge +46.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.95% lower at present.

During the last 5 trading sessions, RPID rose by +30.51%, which changed the moving average for the period of 200-days by +370.23% in comparison to the 20-day moving average, which settled at $2.34. In addition, Rapid Micro Biosystems Inc saw 242.22% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RPID starting from PEI MELINDA LITHERLAND, who purchase 10,880 shares at the price of $1.00 back on Dec 03 ’24. After this action, PEI MELINDA LITHERLAND now owns 45,180 shares of Rapid Micro Biosystems Inc, valued at $10,880 using the latest closing price.

PEI MELINDA LITHERLAND, the Director of Rapid Micro Biosystems Inc, purchase 9,120 shares at $1.04 during a trade that took place back on Dec 05 ’24, which means that PEI MELINDA LITHERLAND is holding 54,300 shares at $9,484 based on the most recent closing price.

Stock Fundamentals for RPID

Current profitability levels for the company are sitting at:

  • -1.78 for the present operating margin
  • -0.0 for the gross margin

The net margin for Rapid Micro Biosystems Inc stands at -1.67. The total capital return value is set at -0.62. Equity return is now at value -52.30, with -42.06 for asset returns.

Based on Rapid Micro Biosystems Inc (RPID), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -7.16.

Currently, EBITDA for the company is -46.56 million with net debt to EBITDA at 0.23. When we switch over and look at the enterprise to sales, we see a ratio of 4.43. The receivables turnover for the company is 3.73for trailing twelve months and the total asset turnover is 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.61.

Conclusion

In summary, Rapid Micro Biosystems Inc (RPID) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Most Popular

Related Posts